More: About Us | Feedback | Privacy


Buy Parsvnath Developers - Religare



Ranbaxy Group promoted Religare, in a research report initiating coverage on PAN India Realty Developer Parsvnath Developers has put a BUY recommendation with a price target of Rs 512.
Parsvnath is expected to report topline of Rs 2,574 crore for FY-2008 and Rs 4,324 crore for FY-2009. Corresponding bottom line is expected to be Rs 555.7 crore and Rs 970 crore giving a fully diluted EPS of Rs 31.1 and Rs 54. Parsvnath Developers is trading at a P/E multiple of mere 10.8 and 6.2 on projected earnings way below the industry average of 17.3 and 14.8. Buy with a price target of Rs 512.

Other Equity Analysis